Limosilactobacillus reuteri DSM 17938 as a probiotic in preterm infants: an updated systematic review with meta-analysis and trial sequential analysis

CONCLUSIONS: Very low CoE suggests that LR DSM 17938 may reduce risk of NEC, LOS, and shorten TFF in preterm infants. Additional RCTs are required to increase sample size and CoE. This article is protected by copyright. All rights reserved.PMID:37742098 | DOI:10.1002/jpen.2564
Source: JPEN Journal Of Parenteral And Enteral Nutrition - Category: Nutrition Authors: Source Type: research